Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Johns Hopkins University
Baltimore, United States
Mayo Clinic
Rochester, United States
Institut Gustave Roussy
Villejuif, France
The European Academy of Gynaecological Surgery
Leuven, Belgium
Memorial Sloan Kettering Cancer Center
New York, United States
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Naples, Italy
Kliniken Essen-Mitte
Essen, Germany
The University of Queensland
Brisbane, Australia
Brigham and Women's Hospital
Boston, United States
European Institute of Oncology
Milan, Italy
References
References (13)
- 1
Who should operate on patients with ovarian cancer? An evidence-based review.
Giede KC, Kieser K, Dodge J, Rosen B
Gynecologic oncology 2005; (99(2)):447-61 doi:10.1016/j.ygyno.2005.07.008.
PMID: 16126262 - 2
The incidence of primary fallopian tube cancer in the United States.
Stewart SL, Wike JM, Foster SL, Michaud F
Gynecologic oncology 2007; (107(3)):392-7 doi:10.1016/j.ygyno.2007.09.018.
PMID: 17961642 - 3
Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.
Wethington SL, Herzog TJ, Seshan VE, et al.
Cancer 2008; (113(12)):3298-306 doi:10.1002/cncr.23957.
PMID: 19006196 - 4
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Rustin GJ, van der Burg ME, Griffin CL, et al.
Lancet (London, England) 2010; (376(9747)):1155-63 doi:10.1016/S0140-6736(10)61268-8.
PMID: 20888993 - 5
The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
Zeppernick F, Meinhold-Heerlein I
Archives of gynecology and obstetrics 2014; (290(5)):839-42 doi:10.1007/s00404-014-3364-8.
PMID: 25082067 - 6
Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.
Ma Y, Duan W
World journal of surgical oncology 2014; (12()):311 doi:10.1186/1477-7819-12-311.
PMID: 25307473 - 7
High grade serous ovarian carcinomas originate in the fallopian tube.
Labidi-Galy SI, Papp E, Hallberg D, et al.
Nature communications 2017; (8(1)):1093 doi:10.1038/s41467-017-00962-1.
PMID: 29061967 - 8
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
Colombo N, Sessa C, du Bois A, et al.
Annals of oncology : official journal of the European Society for Medical Oncology 2019; (30(5)):672-705 doi:10.1093/annonc/mdz062.
PMID: 31046081 - 9
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Tewari KS, Burger RA, Enserro D, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019; (37(26)):2317-2328 doi:10.1200/JCO.19.01009.
PMID: 31216226 - 10
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, et al.
The New England journal of medicine 2019; (381(25)):2416-2428 doi:10.1056/NEJMoa1911361.
PMID: 31851799 - 11
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
Loprinzi CL, Lacchetti C, Bleeker J, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(28)):3325-3348 doi:10.1200/JCO.20.01399.
PMID: 32663120 - 12
Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S, Scott S, Glanc P, et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2020; (42(8)):1021-1029.e3 doi:10.1016/j.jogc.2019.08.044.
PMID: 32736853 - 13
Clinical characteristics of primary Fallopian tube carcinoma: A single-institution retrospective study of 57 cases.
Ma Z, Gao L, Li H, et al.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2021; (153(3)):405-411 doi:10.1002/ijgo.13497.
PMID: 33230808